Medtronic EBITDA Margin 2010-2025 | MDT
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Medtronic (MDT) over the last 10 years. The current EBITDA margin for Medtronic as of April 30, 2025 is .
| Medtronic EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-04-30 | $33.54B | $8.82B | 26.29% |
| 2025-01-31 | $33.20B | $8.25B | 24.84% |
| 2024-10-31 | $33.00B | $8.05B | 24.40% |
| 2024-07-31 | $32.58B | $7.79B | 23.92% |
| 2024-04-30 | $32.36B | $7.79B | 24.08% |
| 2024-01-31 | $32.32B | $8.33B | 25.78% |
| 2023-10-31 | $31.96B | $8.27B | 25.88% |
| 2023-07-31 | $31.56B | $8.33B | 26.40% |
| 2023-04-30 | $31.23B | $8.18B | 26.20% |
| 2023-01-31 | $30.77B | $8.30B | 26.96% |
| 2022-10-31 | $30.81B | $8.56B | 27.78% |
| 2022-07-31 | $31.07B | $8.72B | 28.07% |
| 2022-04-30 | $31.69B | $8.46B | 26.70% |
| 2022-01-31 | $31.79B | $8.39B | 26.39% |
| 2021-10-31 | $31.80B | $8.01B | 25.20% |
| 2021-07-31 | $31.60B | $7.37B | 23.34% |
| 2021-04-30 | $30.12B | $7.19B | 23.86% |
| 2021-01-31 | $27.93B | $5.89B | 21.08% |
| 2020-10-31 | $27.87B | $6.23B | 22.37% |
| 2020-07-31 | $27.93B | $6.65B | 23.83% |
| 2020-04-30 | $28.91B | $7.45B | 25.78% |
| 2020-01-31 | $31.06B | $9.08B | 29.23% |
| 2019-10-31 | $30.89B | $8.99B | 29.12% |
| 2019-07-31 | $30.67B | $9.17B | 29.89% |
| 2019-04-30 | $30.56B | $8.93B | 29.21% |
| 2019-01-31 | $30.56B | $8.91B | 29.15% |
| 2018-10-31 | $30.38B | $8.79B | 28.94% |
| 2018-07-31 | $29.95B | $9.17B | 30.61% |
| 2018-04-30 | $29.95B | $9.28B | 31.00% |
| 2018-01-31 | $29.73B | $9.07B | 30.52% |
| 2017-10-31 | $29.64B | $8.86B | 29.88% |
| 2017-07-31 | $29.93B | $8.41B | 28.09% |
| 2017-04-30 | $29.71B | $8.30B | 27.94% |
| 2017-01-31 | $29.36B | $8.21B | 27.96% |
| 2016-10-31 | $29.01B | $8.40B | 28.96% |
| 2016-07-31 | $28.73B | $8.28B | 28.83% |
| 2016-04-30 | $28.83B | $8.21B | 28.47% |
| 2016-01-31 | $28.57B | $6.76B | 23.67% |
| 2015-10-31 | $25.95B | $6.24B | 24.03% |
| 2015-07-31 | $23.26B | $5.63B | 24.22% |
| 2015-04-30 | $20.26B | $5.15B | 25.41% |
| 2015-01-31 | $17.52B | $4.83B | 27.55% |
| 2014-10-31 | $17.37B | $4.52B | 26.01% |
| 2014-07-31 | $17.20B | $4.54B | 26.39% |
| 2014-04-30 | $17.01B | $4.67B | 27.47% |
| 2014-01-31 | $16.90B | $5.58B | 33.04% |
| 2013-10-31 | $16.76B | $5.80B | 34.59% |
| 2013-07-31 | $16.67B | $5.79B | 34.71% |
| 2013-04-30 | $16.59B | $5.68B | 34.23% |
| 2013-01-31 | $16.43B | $5.68B | 34.58% |
| 2012-10-31 | $16.32B | $5.61B | 34.37% |
| 2012-07-31 | $16.25B | $5.66B | 34.81% |
| 2012-04-30 | $16.18B | $5.67B | 35.01% |
| 2012-01-31 | $15.86B | $5.47B | 34.45% |
| 2011-10-31 | $15.80B | $5.46B | 34.57% |
| 2011-07-31 | $15.68B | $5.35B | 34.14% |
| 2011-04-30 | $15.51B | $5.27B | 34.00% |
| 2011-01-31 | $15.30B | $5.34B | 34.90% |
| 2010-10-31 | $15.30B | $5.46B | 35.71% |
| 2010-07-31 | $15.23B | $5.56B | 36.53% |
| 2010-04-30 | $15.39B | $5.65B | 36.73% |
| 2010-01-31 | $15.45B | $5.23B | 33.82% |
| 2009-10-31 | $15.09B | $4.91B | 32.54% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $114.146B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.781B | 27.87 |
| Boston Scientific (BSX) | United States | $152.324B | 38.13 |
| Stryker (SYK) | United States | $149.641B | 31.29 |
| EssilorLuxottica (ESLOY) | France | $137.721B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.237B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.147B | 25.77 |
| ResMed (RMD) | United States | $37.534B | 28.19 |
| GE HealthCare Technologies (GEHC) | United States | $34.575B | 16.42 |
| Agilent Technologies (A) | United States | $34.457B | 22.46 |
| Terumo (TRUMY) | Japan | $25.051B | 32.54 |
| Koninklijke Philips (PHG) | Netherlands | $23.235B | 16.30 |
| Insulet (PODD) | United States | $20.934B | 82.17 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.835B | 12.10 |
| Baxter (BAX) | United States | $15.298B | 11.42 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.441B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.887B | 23.97 |
| Lantheus Holdings (LNTH) | United States | $5.776B | 14.57 |
| Prestige Consumer Healthcare (PBH) | United States | $3.897B | 17.41 |
| Perrigo (PRGO) | Ireland | $3.742B | 9.48 |
| Haemonetics (HAE) | United States | $3.724B | 16.96 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.454B | 28.70 |
| ICU Medical (ICUI) | United States | $3.341B | 24.63 |
| QuidelOrtho (QDEL) | United States | $2.135B | 14.68 |
| LeMaitre Vascular (LMAT) | United States | $1.910B | 42.70 |
| AtriCure (ATRC) | United States | $1.580B | 0.00 |
| Acuren (TIC) | United States | $1.397B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.272B | 16.26 |
| Green Thumb Industries (GTBIF) | United States | $1.249B | 28.09 |
| AdaptHealth (AHCO) | United States | $1.247B | 12.66 |
| Neogen (NEOG) | United States | $1.194B | 15.28 |
| BioLife Solutions (BLFS) | United States | $1.068B | 0.00 |
| InMode (INMD) | Israel | $0.963B | 9.70 |
| Kestra Medical Technologies (KMTS) | United States | $0.791B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.703B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.679B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
| Owens & Minor (OMI) | United States | $0.667B | 5.53 |
| Evolus (EOLS) | United States | $0.623B | 0.00 |
| CeriBell (CBLL) | United States | $0.596B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.522B | 0.00 |
| Valneva SE (VALN) | France | $0.502B | 0.00 |
| Surmodics (SRDX) | United States | $0.441B | 0.00 |
| SNDL (SNDL) | Canada | $0.373B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.347B | 12.77 |
| Sanuwave Health (SNWV) | United States | $0.308B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.295B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.285B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 23.27 |
| Sanara MedTech (SMTI) | United States | $0.269B | 0.00 |
| ZimVie (ZIMV) | United States | $0.264B | 12.01 |
| Aurora Cannabis (ACB) | Canada | $0.257B | 76.17 |
| Brainsway (BWAY) | Israel | $0.246B | 65.00 |
| Canopy Growth (CGC) | Canada | $0.232B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.227B | 0.00 |
| Biote (BTMD) | United States | $0.225B | 6.34 |
| Verano Holdings (VRNOF) | United States | $0.210B | 0.00 |
| Omeros (OMER) | United States | $0.198B | 0.00 |
| Organigram Global (OGI) | Canada | $0.193B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.15 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| Exagen (XGN) | United States | $0.145B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.126B | 15.53 |
| TerrAscend (TSNDF) | Canada | $0.104B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.37 |
| Jin Medical (ZJYL) | China | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.082B | 0.00 |
| Veru (VERU) | United States | $0.081B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Agape ATP (ATPC) | $0.071B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.070B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.041B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 53.29 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.82 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |